Strategic Partnerships BioSensics has a history of collaborative research with medical foundations and hospitals (e.g., Hereditary Neuropathy Foundation and Spaulding Rehabilitation Hospital) and ongoing NIH-funded projects. This presents opportunities to position complementary wearable sensor solutions and digital biomarkers within clinical trials, patient registries, and post-acute care programs.

Clinical Validation Focus Recent and upcoming studies and pilots around digital biomarkers for PSP, DLB, CMT, and stroke monitoring indicate demand for rapid deployment of validated wearables in research and healthcare settings. Sales conversations can emphasize end-to-end validation, regulatory alignment, and integration with clinical trial workflows.

Caregiving Enablement BioSensics’ Nili caregiving solution and partnerships with senior-focused platforms (like Feed Media Group integration) suggest strong potential in aging-in-place programs, home health monitoring, and value-based care initiatives that require scalable digital caregiving tools.

Data & Analytics Strength With a stack centered on digital biomarkers, outcome assessment, and analytics (HubSpot, Vue.js, TypeScript, etc.), there is an opportunity to upsell through expanded data insights, dashboarding, and interoperability with health information systems (EHR/EMR) to support clinical decision-making.

Funding & Growth NIH funding and multi-year grants indicate a receptive environment for joint go-to-market efforts around novel biomarkers and sensor technologies. Target collaborations with research institutions and biopharma focusing on neurology and movement disorders to accelerate adoption and scale.